-
High Speed Genetics Tech Start-Up Raises $15M
A start-up enterprise developing a high-performance genomic screening and detection technology is raising $15 million in early financing.
-
AI Drug Company Creating Covid-19 Therapy for Rapid Delivery
A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced.
-
Trial Shows Therapy Controls Gut Disorder with Healthy Microbes
Results from a clinical trial show a microbiome treatment produces healthy gut microbes that reduce recurrences of C. difficile infections.
-
Infographic – 100 Promising AI Companies
CB Insights now compiles an annual list of new companies creating A.I. applications and tools, with the 2022 collection published this week.
-
Addiction Therapy, VR Companies Partner on Veteran PTSD
A developer of addiction therapies and virtual reality software company are collaborating on help for veterans suffering from post-traumatic stress disorder.
-
Venture Investor Funds Cell Therapy Targeting Tech
A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases.
-
Precision Antibacterial Company Raises $35M in New Funds
A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds.
-
Companies Partner on Implanted Diabetes Beta Cell Device
A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes.
-
Trial Shows Gene Therapy Results with Sickle Cell Disease
Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years.
-
Infographic – Synthetic Opioids Driving Overdose Deaths
While Covid-19 may grab health headlines in the U.S., the opioid epidemic is not going away, and shifting from prescription to synthetic compounds.